PharMerica CORP Concentration Risk, Percentage
PharMerica CORP reported Concentration Risk, Percentage of 12.50% for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Notes › Consolidation and Presentation of Financial Statements
us-gaap:ConcentrationRiskPercentage1 · last filed 2014-02-28
- PharMerica CORP concentration risk, percentage for fiscal 2013 was 12.50%, a 12.59% decline from fiscal 2012.
- PharMerica CORP concentration risk, percentage for fiscal 2012 was 14.30%, a 8.33% increase from fiscal 2011.
- PharMerica CORP concentration risk, percentage for fiscal 2011 was 13.20%.
| Period end | Concentration Risk, Percentage 12 month |
|---|---|
| 2013-12-31 | 12.50% 10-K · filed 2014-02-28 |
| 2012-12-31 | 14.30% 10-K · filed 2014-02-28 |
| 2011-12-31 | 13.20% 10-K · filed 2014-02-28 |